These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED March 31, 2014
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _______ TO ________.
|
|
Delaware
|
38-1740889
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
c/o Unity Venture Capital Associates Ltd.
825 Third Avenue, New York, New York
|
10022
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
x
|
|
Item 1. Financial Statements
|
|
|
Balance Sheets
|
1
|
|
Statements of Operations
|
2
|
|
Statements of Stockholders' Deficit
|
3
|
|
Statements of Cash Flows
|
4
|
|
Notes to Financial Statements
|
5-6
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
6-7
|
|
Item 4
.
Controls and Procedures
|
7-8
|
|
PART II
|
|
|
OTHER INFORMATION
|
|
|
Item 1A. Risk Factors
|
8
|
|
Item 6. Exhibits
|
8
|
|
Signatures
|
9
|
|
|
March 31,
|
December 31,
|
||||||
|
2014
|
2013
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
CASH
|
$
|
5,232
|
$
|
7,731
|
||||
|
TOTAL ASSETS
|
$
|
5,232
|
$
|
7,731
|
||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
ACCRUED EXPENSES
|
$
|
50,428
|
$
|
43,653
|
||||
|
TOTAL LIABILITIES
|
50,428
|
43,653
|
||||||
|
STOCKHOLDERS' DEFICIT
|
||||||||
|
Pr Preferred stock, $.001 par value; 1,000,000 authorized shares; none issued and outstanding at March 31, 2013 and December 31, 2012
|
-
|
-
|
||||||
|
C Common stock, $.001 par value; 50,000,000 authorized shares, 11,662,104 issued and outstanding at March 31, 2013 and at December 31, 2012
|
11,662
|
11,662
|
||||||
|
ADDITIONAL PAID IN CAPITAL
|
86,838
|
86,838
|
||||||
|
RETAINED DEFICIT
|
(143,696
|
)
|
(134,442
|
)
|
||||
|
TOTAL STOCKHOLDERS' DEFICIT
|
(45,196
|
)
|
(35,922
|
)
|
||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$
|
5,232
|
$
|
7,731
|
||||
|
Three Month Period Ended
March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
REVENUE
|
$
|
-
|
$
|
-
|
||||
|
OPERATING EXPENSES
|
9,275
|
8,450
|
||||||
|
INTEREST INCOME
|
1
|
2
|
||||||
|
NET LOSS
|
$
|
(9,274
|
)
|
$
|
(8,448
|
)
|
||
|
Common Stock
Number of Shares
|
Common Stock
Amount
|
Additional
Paid-in Capital
|
Retained
Deficit
|
Total
|
||||||||||||||||
|
Balance at December 31, 2012
|
11,662,104
|
$
|
11,662
|
$
|
86,838
|
$
|
(102,668
|
)
|
$
|
(4,168
|
)
|
|||||||||
|
Net loss
|
-
|
-
|
-
|
(31,754
|
)
|
(31,754
|
)
|
|||||||||||||
|
Balance at December 31, 2013
|
11,662,104
|
$
|
11,662
|
$
|
86,838
|
$
|
(134,422
|
)
|
$
|
(35,922
|
)
|
|||||||||
|
Net loss
|
-
|
-
|
-
|
(9,274
|
)
|
(9,274
|
)
|
|||||||||||||
|
Balance at March 31, 2014
|
11,662,104
|
$
|
11,662
|
$
|
86,838
|
$
|
(143,696
|
)
|
$
|
(45,196
|
)
|
|||||||||
|
Three Months
Ended March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
9,274
|
$
|
(8,448
|
)
|
|||
|
Change in operating assets and liabilities:
|
||||||||
|
Increase (Decrease) in:
|
||||||||
|
Accrued expenses
|
(6,776
|
)
|
8,450
|
|||||
|
Net cash provided by( used in) operating activities
|
(2,499
|
)
|
2
|
|||||
|
Cash flow from investing activities:
|
|
|||||||
|
Net cash used for investing activities
|
-
|
-
|
||||||
|
Cash flow from financing activities:
|
||||||||
|
Increase in Common Stock
|
-
|
-
|
||||||
|
Increase in Additional Paid in Capital
|
-
|
-
|
||||||
|
Net cash provided by financing activities
|
-
|
-
|
||||||
|
Net increase in cash
|
7,731
|
2
|
||||||
|
Cash at beginning of period
|
||||||||
|
Cash at end of period
|
$
|
5,232
|
$
|
16,828
|
||||
|
31.1
|
Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of1934, as amended.
|
|
31.2
|
Certification of the Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of1934, as amended.
|
|
32.1
|
Certification of the Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
Certification of the Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS*
|
XBRL Instance Document
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition
|
|
101.LAB*
|
XBRL Taxonomy Extension Label
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation
|
|
UHF Incorporated
|
|||
|
Dated: May 14, 2014
|
By:
|
/s/ Omar Cunha
|
|
|
Omar Cunha
|
|||
|
President (Principal Executive Officer)
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|